Welcome to Affectis
Affectis is a biopharmaceutical company implementing novel concepts for
the treatment of depression and anxiety.
| "A conceptually novel antidepressant | ||
| that acted rapidly and safely in a high proportion | ||
| of patients would almost certainly become | ||
| the world's best-selling drug." | ||
| Nature Drug Discovery, Vol. 3, Feb 04, pages 136-151 | ||
